908 Devices Inc.
NASDAQ:MASSMedical - Devices
Healthcare
$9.37 +2.51%
+$0.22 today
- Market cap
- $389.63M
- Beta
- 0.64
- P/E (TTM)
- -9.0
- EPS (TTM)
- -$0.97
52W Low $5.03High $9.34
Volume 0.25M
Average 0.27M
Income Statement
Follow revenue through to earnings.
Revenue
$56.20M
FY 2025 · Annual
-5.8% YoYOperating Income
-$24.18M
FY 2025 · Annual
Net Income
-$36.64M
FY 2025 · Annual
Income Statement
USD
Metric | FY 2021 Dec 2021 | FY 2022 Dec 2022 | FY 2023 Dec 2023 | FY 2024 Dec 2024 | FY 2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 42.21M | 46.85M | 50.23M | 59.63M | 56.2M |
| Cost of Revenue | 18.97M | 20.83M | 24.91M | 29.71M | 29.4M |
| Gross Profit | 23.23M | 26.02M | 25.32M | 29.93M | 26.8M |
| Gross Margin | 55.0% | 55.5% | 50.4% | 50.2% | 47.7% |
| Research & Development | 13.07M | 17.53M | 21.9M | 25.5M | 13.8M |
| Selling, General & Admin | 32.24M | 43.88M | 0 | 0 | 37.18M |
| Operating Expenses | 45.3M | 61.41M | 68.08M | 106.64M | 50.98M |
| Depreciation & Amortization | 925K | 1.61M | 2.38M | 4.68M | 4.47M |
| EBITDA | (20.76M) | (31.82M) | (40.27M) | (43.88M) | (28.88M) |
| EBITDA Margin | -49.2% | -67.9% | -80.2% | -73.6% | -51.4% |
| Operating Income | (22.07M) | (35.38M) | (42.76M) | (76.72M) | (24.18M) |
| Operating Margin | -52.3% | -75.5% | -85.1% | -128.7% | -43.0% |
| Interest Income | 548K | 2.03M | 6.48M | 4.49M | 4.14M |
| Interest Expense | 486K | 129K | 201K | 0 | 0 |
| Other Income / Expenses | (100K) | 1.82M | 6.15M | 4.23M | (9.16M) |
| Income Before Tax | (22.17M) | (33.56M) | (36.61M) | (72.49M) | (33.34M) |
| Pre-Tax Margin | -52.5% | -71.6% | -72.9% | -121.6% | -59.3% |
| Income Tax Expense | 0 | 0 | (211K) | (282K) | (66K) |
| Net Income | (22.17M) | (33.56M) | (36.4M) | (72.21M) | (36.64M) |
| Net Margin | -52.5% | -71.6% | -72.5% | -121.1% | -65.2% |
| EPS (Basic) | (0.79) | (1.07) | (1.13) | (2.12) | 0.54 |
| EPS (Diluted) | (0.79) | (1.07) | (1.13) | (2.12) | 0.54 |
| 27.96M | 31.49M | 32.21M | 34.08M | 36.22M | |
| 27.96M | 31.49M | 32.24M | 34.08M | 38.92M |
MASS Earnings Waterfall · TTM
NASDAQ:MASS · Revenue to Net Income
Key Ratios
EPS$-1.00
Gross Margin48.9%
Net Margin-68.3%
P/E Ratio-0.9
P/S Ratio17.5
Analysis
$57.8M of revenue converted into -$35.9M of net income for the selected period. Gross margin is 48.9% and net margin is -68.3%, showing how much revenue survives after costs and taxes. EPS is $-1.00, tying the income statement back to per-share earnings.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Nov 10, 2026 | |
| 10-Q | Quarterly report | Nov 10, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 6, 2026 | |
| SC 13G/A | SC 13G/A filing | Oct 27, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 9, 2026 |
How much revenue does MASS generate?
908 Devices Inc. (MASS) reported $56.20M of revenue in fiscal 2025.
Is MASS profitable?
908 Devices Inc. (MASS) reported -$36.64M of net income, with a net margin of -65.2%.
Continue the stock analysis
Jump to another research area for this company.